Perrigo Company plc (PRGO)
Market Cap | 4.21B |
Revenue (ttm) | 4.65B |
Net Income (ttm) | -4.10M |
Shares Out | 135.51M |
EPS (ttm) | -0.03 |
PE Ratio | n/a |
Forward PE | 18.73 |
Dividend | $1.09 (3.69%) |
Ex-Dividend Date | Nov 30, 2023 |
Volume | 3,158,514 |
Open | 30.92 |
Previous Close | 30.91 |
Day's Range | 29.34 - 31.07 |
52-Week Range | 26.81 - 40.28 |
Beta | 0.90 |
Analysts | Strong Buy |
Price Target | 44.25 (+49.39%) |
Earnings Date | Nov 7, 2023 |
About PRGO
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in Ireland, the United States, France, Belgium, China, the United Kingdom, Germany, Switzerland, Austria, Italy, Australia, Greece, and Spain. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The Consumer Self-Care Americas segment develops, manufacture, and markets self-care products including upper respiratory, pain and sleep-aids, digestive health, nutrition, healthy lifestyle, skincare, w... [Read more]
Full Company ProfileFinancial Performance
In 2022, PRGO's revenue was $4.45 billion, an increase of 7.56% compared to the previous year's $4.14 billion. Losses were -$140.60 million, 104.1% more than in 2021.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for PRGO stock is "Strong Buy." The 12-month stock price forecast is $44.25, which is an increase of 49.39% from the latest price.
News

Perrigo Announces Early Results of Cash Tender Offer for Notes
DUBLIN , Nov. 29, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) (the "Company"), a leading provider of Consumer Self-Care Products, today announced the early tender results of the previously a...

Perrigo Announces Cash Tender Offer for Notes
DUBLIN , Nov. 10, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) (the "Company"), a leading provider of Consumer Self-Care Products, today announced that Perrigo Finance Unlimited Company, its ...

Perrigo's stock tumbles 14% after sales miss and lowered guidance
Perrigo Co. Plc's stock PRGO, -0.97% fell 14% early Tuesday, after the consumer self-care and wellness products maker posted weaker-than-expected third-quarter sales and lowered its guidance. Dublin, ...

Perrigo Reports Third Quarter Fiscal Year 2023 Financial Results From Continuing Operations
Realized Third Quarter Double-Digit Gross Profit, Operating Income and EPS Growth Year-Over-Year Delivered Third Quarter Gross Margin and Operating Margin Expansion Year-Over-Year and Sequentially Ac...

Perrigo Announces Quarterly Dividend
DUBLIN , Nov. 2, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly divid...

Perrigo to Attend Upcoming Consumer Investor Conferences
DUBLIN , Oct. 31, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO, Patrick Lockwood-Taylor and CFO Edua...

Perrigo to Release Third Quarter 2023 Financial Results on November 7, 2023
DUBLIN , Oct. 24, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its third quarter 2023 financial resu...

Perrigo Announces Leadership Update
Appoints Experienced Consumer Packaged Goods Executive Catherine "Triona" Schmelter as EVP and President, Consumer Self-Care Americas (CSCA) and Global Portfolio Optimization DUBLIN , Sept. 11, 2023 /...

FDA warns three baby-formula makers about production violations
The U.S. Food and Drug Administration said Wednesday it has sent warning letters to three baby-formula makers as part of what the agency called enhanced oversight of the product, which was plagued by ...

Perrigo Reports Second Quarter Fiscal Year 2023 Financial Results From Continuing Operations
Achieved Year-Over-Year and Sequential Gross and Operating Margin Expansion Delivered Strong Operating Income and EPS Growth Reaffirming 2023 Outlook DUBLIN , Aug. 8, 2023 /PRNewswire/ -- Second Quar...

PERRIGO ANNOUNCES QUARTERLY DIVIDEND
DUBLIN, Ireland , Aug. 2, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarte...

Perrigo to Release Second Quarter 2023 Financial Results and Present at an Industry Growth Conference
DUBLIN , July 25, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its second quarter 2023 financial res...
First nonprescription birth control pill approved in U.S.; Perrigo's Opill to hit shelves in 2024
Ibis Reproductive Health President Kelly Blanchard spoke with Yahoo Finance Live anchor Rachelle Akuffo about the FDA approval of Perrigo's Opill to be sold over the counter in the United States.

FDA Approves First Over-the-Counter Birth-Control Pill
The Food and Drug Administration approved the first over-the-counter birth-control pill, significantly expanding access to contraception among women across the U.S.
FDA approves first over-the-counter birth control pill in the U.S.; Perrigo stock jumps
Yahoo Finance Live anchors Julie Hyman and Brad Smith break down the U.S. Food and Drug Administration approving Perrigo over-the-counter birth control pill named OPill. It is the first approval of an...

FDA approves first over-the-counter birth control pill
Perrigo's Opill could significantly expand access to contraception, especially for younger women who often face logistical barriers to get birth control.

FDA Approves First Over-The-Counter Birth Control Pill in U.S. Perrigo Stock Jumps.
The drug will be available in store and online at retailers across the country 'early in the first quarter of 2024,' the company says.

Perrigo's stock soars 6% after FDA approves its over-the-counter daily oral contraceptive
Perrigo Co. PLC's stock PRGO, -0.78% soared 6% in premarket trade Thursday, after the company said the U.S. Food and Drug Administration has approved its over-the-counter daily oral contraceptive. The...

US FDA approves Perrigo's contraceptive pill for over-the-counter use
The U.S. Food and Drug Administration on Thursday approved the over-the-counter use of Perrigo's contraceptive drug, making it the first non-prescription birth control pill in the United States.

Perrigo Announces U.S. FDA Approval for Opill® OTC Daily Oral Contraceptive
DUBLIN , July 13, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced today that the U.S. Food and Drug Administration (FDA) approved Op...

Perrigo hires Bayer's ex-U.S. head as new CEO
Perrigo Co. Plc PRGO, +0.51% on Thursday named Patrick Lockwood-Taylor as its new president and chief executive officer as of June 30. Lockwood-Taylor previously worked in dual roles at Bayer AG as pr...

Perrigo Appoints Patrick Lockwood-Taylor as President and CEO
DUBLIN , June 8, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced the appointment of industry professional Patrick Lockwood-Tay...

Perrigo to Host 1x1 Investor Meetings at the 23rd Annual Oppenheimer Consumer Growth & E-Commerce Conference
DUBLIN , May 24, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it is scheduled to host 1x1 investor meetings at the Opp...

PERRIGO ANNOUNCES U.S. FDA APPROVAL FOR NICOTINE COATED MINT LOZENGE
DUBLIN , May 16, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it has received final approval from the U.S. Food and Dr...

Gerber baby formula with potential bacteria was shipped to stores after recall: feds
Certain lots of Perrigo's Gerber Good Start SoothePro powdered infant formula had been recalled in March out of an abundance of caution due to the potential presence of cronobacter sakazakii.